AVALLONE, GIANLUCA
AVALLONE, GIANLUCA
SCIENZE MEDICHE
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
2022-01-01 Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?
2021-01-01 Mastorino L.; Ortoncelli M.; Avallone G.; Quaglino P.; Ribero S.
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study
2022-01-01 Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P.
Attitudes, characteristics, and occupational-related risk of skin cancer and cutaneous melanoma in the militaries: an observational, cross-sectional, survey-based study
2022-01-01 Cavallo, Francesco; Avallone, Gianluca; Tartaglione, Ciro; Quaglino, Pietro; Ribero, Simone
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?
2021-01-01 Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S.
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome
2022-01-01 Cavallo F.; Roccuzzo G.; Merli M.; Avallone G.; Zocchi L.; Ogliara P.; Pasini B.; Quaglino P.; Ribero S.
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma
2021-01-01 Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients
2021-01-01 Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
2022-01-01 Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
2022-01-01 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic
2022-01-01 Maronese, Carlo Alberto; Zelin, Enrico; Avallone, Gianluca; Moltrasio, Chiara; Romagnuolo, Maurizio; Ribero, Simone; Quaglino, Pietro; Marzano, Angelo Valerio
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy
2023-01-01 Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents
2022-01-01 Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone
Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review
2021-01-01 Avallone G.; Trunfio M.; Giura M.T.; Siliquini N.; Viola R.; Orofino G.; Mastorino L.; Ortoncelli M.; Quaglino P.; Ribero S.
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study
2021-01-01 Mastorino L.; Viola R.; Panzone M.; Avallone G.; Gallo G.; Ortoncelli M.; Cavaliere G.; Quaglino P.; Ribero S.
Dupilumab-induced Urticaria
2021-01-01 Mastorino L.; Ortoncelli M.; Virginia B.; Rolla G.; Avallone G.; Cavaliere G.; Riccardo V.; Quaglino P.; Ribero S.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study
2021-01-01 Dapavo P.; Siliquini N.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Cariti C.; Viola R.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Ribero S.
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
2022-01-01 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome
2021-01-01 Pietro Quaglino, Ada Funaro, Erika Ortolan, Rebecca Senetta, Gianluca Avallone, Martina Merli, Cristiano Bracci, Maria Rebecca Rumore, Yuliya Yakymiv, Maria Teresa Fierro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
| Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review | 2022 | Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro | |
| Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related? | 2021 | Mastorino L.; Ortoncelli M.; Avallone G.; Quaglino P.; Ribero S. | |
| Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study | 2022 | Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P. | |
| Attitudes, characteristics, and occupational-related risk of skin cancer and cutaneous melanoma in the militaries: an observational, cross-sectional, survey-based study | 2022 | Cavallo, Francesco; Avallone, Gianluca; Tartaglione, Ciro; Quaglino, Pietro; Ribero, Simone | |
| Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? | 2021 | Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S. | |
| BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome | 2022 | Cavallo F.; Roccuzzo G.; Merli M.; Avallone G.; Zocchi L.; Ogliara P.; Pasini B.; Quaglino P.; Ribero S. | |
| Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma | 2021 | Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone | |
| Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients | 2021 | Cariti, C; Dapavo, P; Mastorino, L; Ortoncelli, M; Siliquini, N; Merli, M; Avallone, G; Giordano, S; Fabrizio, R; Susca, S; Verrone, A; Stroppiana, E; Quaglino, P; Ribero, S | |
| Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma | 2022 | Nepote A.; Avallone G.; Ribero S.; Cavallo F.; Roccuzzo G.; Mastorino L.; Conforti C.; Paruzzo L.; Poletto S.; Schianca F.C.; Quaglino P.; Aglietta M. | |
| Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study | 2022 | Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P. | |
| Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic | 2022 | Maronese, Carlo Alberto; Zelin, Enrico; Avallone, Gianluca; Moltrasio, Chiara; Romagnuolo, Maurizio; Ribero, Simone; Quaglino, Pietro; Marzano, Angelo Valerio | |
| Dramatic response of face desmoplastic melanoma after two doses of immunotherapy | 2023 | Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro | |
| Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents | 2022 | Roccuzzo, Gabriele; Mastorino, Luca; Susca, Sara; Cariti, Caterina; Passerini, Stefania G; Sciamarrelli, Nadia; Borriello, Silvia; Macagno, Nicole; Sliquini, Niccolò; Avallone, Gianluca; Verrone, Anna; Stroppiana, Elena; Quaglino, Pietro; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone | |
| Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review | 2021 | Avallone G.; Trunfio M.; Giura M.T.; Siliquini N.; Viola R.; Orofino G.; Mastorino L.; Ortoncelli M.; Quaglino P.; Ribero S. | |
| Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study | 2021 | Mastorino L.; Viola R.; Panzone M.; Avallone G.; Gallo G.; Ortoncelli M.; Cavaliere G.; Quaglino P.; Ribero S. | |
| Dupilumab-induced Urticaria | 2021 | Mastorino L.; Ortoncelli M.; Virginia B.; Rolla G.; Avallone G.; Cavaliere G.; Riccardo V.; Quaglino P.; Ribero S. | |
| Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study | 2021 | Dapavo P.; Siliquini N.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Cariti C.; Viola R.; Stroppiana E.; Verrone A.; Ortoncelli M.; Quaglino P.; Ribero S. | |
| Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? | 2022 | Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome | 2021 | Pietro Quaglino, Ada Funaro, Erika Ortolan, Rebecca Senetta, Gianluca Avallone, Martina Merli, Cristiano Bracci, Maria Rebecca Rumore, Yuliya Yakymiv, Maria Teresa Fierro |